{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:20:01Z","timestamp":1792153201053,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021771","name":"Student Research Committee, Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["69049"],"award-info":[{"award-number":["69049"]}],"id":[{"id":"10.13039\/501100021771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-53253-5","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:44:46Z","timestamp":1778759086000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The correlation between serum markers of oxidative stress and fatigue and related factors in minimally disabled patients with relapsing-remitting multiple sclerosis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4752-0394","authenticated-orcid":false,"given":"Ali","family":"Alipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3353-1102","authenticated-orcid":false,"given":"Reza","family":"Mosaddeghi-Heris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0584-8750","authenticated-orcid":false,"given":"Afra","family":"Darvishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0709-5017","authenticated-orcid":false,"given":"Shahriar","family":"Parvaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malihe","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9514-4968","authenticated-orcid":false,"given":"Niloofar","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7613-3913","authenticated-orcid":false,"given":"Mahnaz","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirreza","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"1","key":"53253_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41392-025-02415-4","volume":"10","author":"I Boutitah-Benyaich","year":"2025","unstructured":"Boutitah-Benyaich, I. et al. Multiple sclerosis: molecular pathogenesis and therapeutic intervention. Signal. Transduct. Target. Ther. 10 (1), 324. https:\/\/doi.org\/10.1038\/s41392-025-02415-4 (2025).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"3","key":"53253_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1515\/revneuro-2023-0091","volume":"35","author":"A Sanabria-Castro","year":"2024","unstructured":"Sanabria-Castro, A., Alape-Gir\u00f3n, A., Flores-D\u00edaz, M., Echeverri-McCandless, A. & Parajeles-Vindas, A. Oxidative stress involvement in the molecular pathogenesis and progression of multiple sclerosis: a literature review. Rev. Neurosci. 35 (3), 355\u2013371. https:\/\/doi.org\/10.1515\/revneuro-2023-0091 (2024).","journal-title":"Rev. Neurosci."},{"key":"53253_CR3","doi-asserted-by":"publisher","first-page":"103432","DOI":"10.1016\/j.msard.2021.103432","volume":"57","author":"A Naseri","year":"2022","unstructured":"Naseri, A. et al. Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients. Mult Scler. Relat. Disord. 57, 103432. https:\/\/doi.org\/10.1016\/j.msard.2021.103432 (2022).","journal-title":"Mult Scler. Relat. Disord"},{"key":"53253_CR4","doi-asserted-by":"publisher","first-page":"110990","DOI":"10.1016\/j.jocn.2024.110990","volume":"132","author":"S Daneshvar","year":"2025","unstructured":"Daneshvar, S. et al. Association of serum levels of inflammation and oxidative stress markers with cognitive outcomes in multiple sclerosis; a systematic review. J. Clin. Neurosci. 132, 110990. https:\/\/doi.org\/10.1016\/j.jocn.2024.110990 (2025).","journal-title":"J. Clin. Neurosci."},{"issue":"6","key":"53253_CR5","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1007\/s10072-020-04807-6","volume":"42","author":"M Talebi","year":"2021","unstructured":"Talebi, M., Majdi, A., Nasiri, E., Naseri, A. & Sadigh-Eteghad, S. The correlation between circulating inflammatory, oxidative stress, and neurotrophic factors level with the cognitive outcomes in multiple sclerosis patients. Neurol. Sci. 42 (6), 2291\u20132300. https:\/\/doi.org\/10.1007\/s10072-020-04807-6 (2021).","journal-title":"Neurol. Sci."},{"key":"53253_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.smrv.2018.03.007","volume":"41","author":"G Morris","year":"2018","unstructured":"Morris, G. et al. The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis. Sleep. Med. Rev. 41, 255\u2013265. https:\/\/doi.org\/10.1016\/j.smrv.2018.03.007 (2018).","journal-title":"Sleep. Med. Rev."},{"issue":"5","key":"53253_CR7","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s10787-023-01271-4","volume":"31","author":"S Morsali","year":"2023","unstructured":"Morsali, S. et al. Clinical efficacy and safety of melatonin supplementation in multiple sclerosis: a systematic review. Inflammopharmacology 31 (5), 2213\u20132220. https:\/\/doi.org\/10.1007\/s10787-023-01271-4 (2023).","journal-title":"Inflammopharmacology"},{"issue":"3","key":"53253_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.34172\/ps.025.41013","volume":"31","author":"A Naseri","year":"2025","unstructured":"Naseri, A. et al. The Effects of Probiotic Supplementation on Level of Disability, Depressive Symptoms, and Cognitive Outcomes in Relapsing-Remitting Multiple Sclerosis Patients: A Randomized Double-Blind Placebo-Controlled Trial. Pharm. Sci. 31 (3), 322\u2013329. https:\/\/doi.org\/10.34172\/ps.025.41013 (2025).","journal-title":"Pharm. Sci."},{"issue":"10","key":"53253_CR9","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.neurol.2023.07.017","volume":"180","author":"H Abbasi","year":"2024","unstructured":"Abbasi, H. et al. Mediterranean-like diets in multiple sclerosis: A systematic review. Rev. Neurol. 180 (10), 1021\u20131030. https:\/\/doi.org\/10.1016\/j.neurol.2023.07.017 (2024).","journal-title":"Rev. Neurol."},{"key":"53253_CR10","unstructured":"Naseri, A., Sanaie, S., Abdolrahmanzadeh, R., Mosaddeghi-Heris, R. & Talebi, M. (eds) The effects of probiotics supplementation on fatigue in relapsing-remitting multiple sclerosis; a randomized double-blinded placebo-controlled trial. MULTIPLE SCLEROSIS JOURNAL; 2025: SAGE PUBLICATIONS LTD 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND."},{"key":"53253_CR11","doi-asserted-by":"publisher","first-page":"104481","DOI":"10.1016\/j.msard.2022.104481","volume":"70","author":"S Englund","year":"2023","unstructured":"Englund, S. et al. Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort. Mult Scler. Relat. Disord. 70, 104481. https:\/\/doi.org\/10.1016\/j.msard.2022.104481 (2023).","journal-title":"Mult Scler. Relat. Disord"},{"issue":"1","key":"53253_CR12","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s12883-021-02396-1","volume":"21","author":"A Oliva Ramirez","year":"2021","unstructured":"Oliva Ramirez, A. et al. Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review. BMC Neurol. 21 (1), 468. https:\/\/doi.org\/10.1186\/s12883-021-02396-1 (2021).","journal-title":"BMC Neurol."},{"issue":"2","key":"53253_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/01376517-200804000-00005","volume":"40","author":"SL Johnson","year":"2008","unstructured":"Johnson, S. L. The concept of fatigue in multiple sclerosis. J. Neurosci. Nurs. 40 (2), 72\u201377. https:\/\/doi.org\/10.1097\/01376517-200804000-00005 (2008).","journal-title":"J. Neurosci. Nurs."},{"key":"53253_CR14","doi-asserted-by":"publisher","first-page":"102533","DOI":"10.1016\/j.msard.2020.102533","volume":"46","author":"H Ormstad","year":"2020","unstructured":"Ormstad, H. et al. Chronic fatigue and depression due to multiple sclerosis: Immune-inflammatory pathways, tryptophan catabolites and the gut-brain axis as possible shared pathways. Mult Scler. Relat. Disord. 46, 102533. https:\/\/doi.org\/10.1016\/j.msard.2020.102533 (2020).","journal-title":"Mult Scler. Relat. Disord"},{"key":"53253_CR15","doi-asserted-by":"publisher","unstructured":"Aparicio-Castro, E., Candeliere-Merlicco, A., Santa, C. M. & Villaverde-Gonz\u00e1lez, R. Association of depression in multiple sclerosis with fatigue, sleep disturbances, disability, and health-related quality of life: Outcomes of a cross-sectional study. Neurol. Perspect. 5 (1). https:\/\/doi.org\/10.1016\/j.neurop.2024.100181 (2025).","DOI":"10.1016\/j.neurop.2024.100181"},{"issue":"1","key":"53253_CR16","doi-asserted-by":"publisher","first-page":"22983","DOI":"10.1038\/s41598-025-07429-0","volume":"15","author":"R Pi\u00f1ar-Morales","year":"2025","unstructured":"Pi\u00f1ar-Morales, R. et al. The impact of oxidative stress on symptoms associated with multiple sclerosis. Sci. Rep. 15 (1), 22983. https:\/\/doi.org\/10.1038\/s41598-025-07429-0 (2025).","journal-title":"Sci. Rep."},{"issue":"4","key":"53253_CR17","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s13760-018-1015-8","volume":"120","author":"V Katarina","year":"2020","unstructured":"Katarina, V., Gordana, T., Svetlana, M. D. & Milica, B. Oxidative stress and neuroinflammation should be both considered in the occurrence of fatigue and depression in multiple sclerosis. Acta Neurol. Belg. 120 (4), 853\u2013861. https:\/\/doi.org\/10.1007\/s13760-018-1015-8 (2020).","journal-title":"Acta Neurol. Belg."},{"issue":"9","key":"53253_CR18","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.1007\/s00415-024-12524-9","volume":"271","author":"J DeLuca","year":"2024","unstructured":"DeLuca, J. Fatigue in multiple sclerosis: can we measure it and can we treat it? J. Neurol. 271 (9), 6388\u20136392. https:\/\/doi.org\/10.1007\/s00415-024-12524-9 (2024).","journal-title":"J. Neurol."},{"issue":"8","key":"53253_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/14737175.2022.2106854","volume":"22","author":"O Marchesi","year":"2022","unstructured":"Marchesi, O., Vizzino, C., Filippi, M. & Rocca, M. A. Current perspectives on the diagnosis and management of fatigue in multiple sclerosis. Expert Rev. Neurother. 22 (8), 681\u2013693. https:\/\/doi.org\/10.1080\/14737175.2022.2106854 (2022).","journal-title":"Expert Rev. Neurother."},{"issue":"2","key":"53253_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/s1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17 (2), 162\u2013173. https:\/\/doi.org\/10.1016\/s1474-4422(17)30470-2 (2018).","journal-title":"Lancet Neurol."},{"key":"53253_CR21","unstructured":"Forwell, S. & Ghahari, S. Comprehensive fatigue assessment battery for multiple sclerosis: A practice tool2013."},{"issue":"131","key":"53253_CR22","first-page":"56","volume":"25","author":"F Motaharinezhad","year":"2015","unstructured":"Motaharinezhad, F. et al. Validation of Persian Version of Comprehensive Fatigue Assessment Battery for Multiple Sclerosis (CFAB-MS). J-Mazand-Univ-Med-Sci 25 (131), 56 (2015).","journal-title":"J-Mazand-Univ-Med-Sci"},{"key":"53253_CR23","doi-asserted-by":"publisher","unstructured":"Kim, S., Jung, U. J. & Kim, S. R. Role of Oxidative Stress in Blood-Brain Barrier Disruption and Neurodegenerative Diseases. Antioxid. (Basel). 13 (12). https:\/\/doi.org\/10.3390\/antiox13121462 (2024).","DOI":"10.3390\/antiox13121462"},{"issue":"1","key":"53253_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12883-025-04127-2","volume":"25","author":"Y Coluk","year":"2025","unstructured":"Coluk, Y., Yildirim, G., Yildirmak, S. & Peker, E. G. G. Altered brain-derived neurotrophic factor levels and oxidative stress in REM sleep deprivation: a rat model study. BMC Neurol. 25 (1), 122. https:\/\/doi.org\/10.1186\/s12883-025-04127-2 (2025).","journal-title":"BMC Neurol."},{"key":"53253_CR25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3389\/fnins.2020.00823","volume":"14","author":"SY Zhang","year":"2020","unstructured":"Zhang, S. Y., Gui, L. N., Liu, Y. Y., Shi, S. & Cheng, Y. Oxidative Stress Marker Aberrations in Multiple Sclerosis: A Meta-Analysis Study. Front. Neurosci. 14, 823. https:\/\/doi.org\/10.3389\/fnins.2020.00823 (2020).","journal-title":"Front. Neurosci."},{"issue":"4","key":"53253_CR26","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s11325-021-02293-4","volume":"25","author":"R Fadaei","year":"2021","unstructured":"Fadaei, R. et al. Increased the circulating levels of malondialdehyde in patients with obstructive sleep apnea: a systematic review and meta-analysis. Sleep. Breath. 25 (4), 1753\u20131760. https:\/\/doi.org\/10.1007\/s11325-021-02293-4 (2021).","journal-title":"Sleep. Breath."},{"issue":"5","key":"53253_CR27","doi-asserted-by":"publisher","first-page":"300060522109499","DOI":"10.1177\/03000605221094995","volume":"50","author":"MA Alvarez-Mon","year":"2022","unstructured":"Alvarez-Mon, M. A. et al. Differential malondialdehyde (MDA) detection in plasma samples of patients with major depressive disorder (MDD): A potential biomarker. J. Int. Med. Res. 50 (5), 3000605221094995. https:\/\/doi.org\/10.1177\/03000605221094995 (2022).","journal-title":"J. Int. Med. Res."},{"issue":"2","key":"53253_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.38053\/acmj.1395276","volume":"6","author":"Y Da\u011fc\u0131","year":"2024","unstructured":"Da\u011fc\u0131, Y., Bilge, N., Ceylan, M. & \u00d6zkan, H. \u0130. The relationship between melatonin level, oxidative stress, fatigue and sleep disorders in multiple sclerosis patients. Anatol. Curr. Med. J. 6 (2), 168\u2013174. https:\/\/doi.org\/10.38053\/acmj.1395276 (2024).","journal-title":"Anatol. Curr. Med. J."},{"issue":"10","key":"53253_CR29","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3390\/nu4101399","volume":"4","author":"WM Johnson","year":"2012","unstructured":"Johnson, W. M., Wilson-Delfosse, A. L. & Mieyal, J. J. Dysregulation of glutathione homeostasis in neurodegenerative diseases. Nutrients 4 (10), 1399\u20131440. https:\/\/doi.org\/10.3390\/nu4101399 (2012).","journal-title":"Nutrients"},{"issue":"6","key":"53253_CR30","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1111\/epi.18338","volume":"66","author":"S Beniczky","year":"2025","unstructured":"Beniczky, S. et al. Updated classification of epileptic seizures: Position paper of the International League Against Epilepsy. Epilepsia 66 (6), 1804\u20131823. https:\/\/doi.org\/10.1111\/epi.18338 (2025).","journal-title":"Epilepsia"},{"key":"53253_CR31","doi-asserted-by":"publisher","unstructured":"Barcelos, I. P., Troxell, R. M. & Graves, J. S. Mitochondrial Dysfunction and Multiple Sclerosis. Biology (Basel). 8 (2). https:\/\/doi.org\/10.3390\/biology8020037 (2019).","DOI":"10.3390\/biology8020037"},{"issue":"2","key":"53253_CR32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.taap.2014.04.014","volume":"278","author":"T Rajah","year":"2014","unstructured":"Rajah, T. & Chow, S. C. The inhibition of human T cell proliferation by the caspase inhibitor z-VAD-FMK is mediated through oxidative stress. Toxicol. Appl. Pharmacol. 278 (2), 100\u2013106. https:\/\/doi.org\/10.1016\/j.taap.2014.04.014 (2014).","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"12","key":"53253_CR33","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1089\/ars.2011.4073","volume":"18","author":"P Kesarwani","year":"2013","unstructured":"Kesarwani, P., Murali, A. K., Al-Khami, A. A. & Mehrotra, S. Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease. Antioxid. Redox Signal. 18 (12), 1497\u20131534. https:\/\/doi.org\/10.1089\/ars.2011.4073 (2013).","journal-title":"Antioxid. Redox Signal."},{"issue":"9","key":"53253_CR34","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/nbm.2772","volume":"25","author":"DC Shungu","year":"2012","unstructured":"Shungu, D. C. et al. Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed. 25 (9), 1073\u20131087. https:\/\/doi.org\/10.1002\/nbm.2772 (2012).","journal-title":"NMR Biomed."},{"issue":"2","key":"53253_CR35","doi-asserted-by":"publisher","first-page":"R120","DOI":"10.1152\/ajpregu.00097.2022","volume":"325","author":"D Watanabe","year":"2023","unstructured":"Watanabe, D. & Wada, M. Glutathione depression alters cellular mechanisms of skeletal muscle fatigue in early stage of recovery and prolongs force depression in late stage of recovery. Am. J. Physiol. Regul. Integr. Comp. Physiol. 325 (2), R120\u2013r32. https:\/\/doi.org\/10.1152\/ajpregu.00097.2022 (2023).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"3","key":"53253_CR36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/jon.12836","volume":"31","author":"J Arm","year":"2021","unstructured":"Arm, J. et al. Biochemical Correlations with Fatigue in Multiple Sclerosis Detected by MR 2D Localized Correlated Spectroscopy. J. Neuroimaging. 31 (3), 508\u2013516. https:\/\/doi.org\/10.1111\/jon.12836 (2021).","journal-title":"J. Neuroimaging"},{"key":"53253_CR37","doi-asserted-by":"publisher","unstructured":"Bizo\u0144, A., Chojdak-\u0141ukasiewicz, J., Budrewicz, S., Pokryszko-Dragan, A. & Piwowar, A. Exploring the Relationship between Antioxidant Enzymes, Oxidative Stress Markers, and Clinical Profile in Relapsing-Remitting Multiple Sclerosis. Antioxid. (Basel). 12 (8). https:\/\/doi.org\/10.3390\/antiox12081638 (2023).","DOI":"10.3390\/antiox12081638"},{"issue":"1","key":"53253_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.34172\/jrcm.2022.023","volume":"10","author":"S Hosseini","year":"2022","unstructured":"Hosseini, S. et al. Fatigue in multiple sclerosis is a diagnostic challenge: A cross-sectional study. J. Res. Clin. Med. 10 (1), 23. https:\/\/doi.org\/10.34172\/jrcm.2022.023 (2022).","journal-title":"J. Res. Clin. Med."},{"issue":"6","key":"53253_CR39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s40271-025-00759-1","volume":"18","author":"T Namsrai","year":"2025","unstructured":"Namsrai, T. et al. Measuring Fatigue in Multiple Sclerosis: A Rapid Review. Patient 18 (6), 623\u2013644. https:\/\/doi.org\/10.1007\/s40271-025-00759-1 (2025).","journal-title":"Patient"},{"key":"53253_CR40","doi-asserted-by":"publisher","first-page":"106528","DOI":"10.1016\/j.msard.2025.106528","volume":"100","author":"A Balshi","year":"2025","unstructured":"Balshi, A. et al. Clinical characteristics associated with multiple sclerosis fatigue severity. Multiple Scler. Relat. Disorders. 100, 106528. https:\/\/doi.org\/10.1016\/j.msard.2025.106528 (2025).","journal-title":"Multiple Scler. Relat. Disorders"},{"key":"53253_CR41","doi-asserted-by":"publisher","first-page":"103954","DOI":"10.1016\/j.msard.2022.103954","volume":"64","author":"H Moore","year":"2022","unstructured":"Moore, H. et al. Fatigue in multiple sclerosis: A UK MS-register based study. Mult Scler. Relat. Disord. 64, 103954. https:\/\/doi.org\/10.1016\/j.msard.2022.103954 (2022).","journal-title":"Mult Scler. Relat. Disord"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53253-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53253-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53253-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:50:09Z","timestamp":1784069409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53253-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53253"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53253-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Tabriz University of Medical Sciences (Ethics code: IR.TBZMED.REC.1401.249).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written consent was obtained from all participants prior to study inclusion, including consent for the publication of anonymized data.","order":3,"name":"Ethics","label":"Consent for publication and participation","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22109"}}